16122394|t|Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans.
16122394|a|BACKGROUND: Epidemiological studies have associated estrogen replacement therapy with a lower risk of developing Alzheimer's disease, but a higher risk of developing breast cancer and certain cardiovascular disorders. The neuroprotective effect of estrogen prompted us to determine potential therapeutic impact of soy-derived estrogenic compounds. Transgenic C. elegans, that express human beta amyloid (Abeta), were fed with soy derived isoflavones genistein, daidzein and glycitein (100 microg/ml) and then examined for Abeta-induced paralysis and the levels of reactive oxygen species. RESULTS: Among the three compounds tested, only glycitein alleviated Abeta expression-induced paralysis in the transgenic C. elegans. This activity of glycitein correlated with a reduced level of hydrogen peroxide in the transgenic C. elegans. In vitro scavenging effects of glycitein on three types of reactive oxygen species confirmed its antioxidant properties. Furthermore, the transgenic C. elegans fed with glycitein exhibited reduced formation of beta amyloid. CONCLUSION: These findings suggest that a specific soy isoflavone glycitein may suppress Abeta toxicity through combined antioxidative activity and inhibition of Abeta deposition, thus may have therapeutic potential for prevention of Abeta associated neurodegenerative disorders.
16122394	0	14	Soy isoflavone	Chemical	MESH:D007529
16122394	15	24	glycitein	Chemical	MESH:C086566
16122394	63	71	toxicity	Disease	MESH:D064420
16122394	107	129	Caenorhabditis elegans	Species	6239
16122394	244	263	Alzheimer's disease	Disease	MESH:D000544
16122394	297	310	breast cancer	Disease	MESH:D001943
16122394	323	347	cardiovascular disorders	Disease	MESH:D002318
16122394	445	448	soy	Species	
16122394	490	500	C. elegans	Species	328850
16122394	515	520	human	Species	9606
16122394	535	540	Abeta	Gene	351
16122394	557	560	soy	Species	
16122394	569	580	isoflavones	Chemical	MESH:D007529
16122394	581	590	genistein	Chemical	MESH:D019833
16122394	592	600	daidzein	Chemical	MESH:C004742
16122394	605	614	glycitein	Chemical	MESH:C086566
16122394	653	658	Abeta	Gene	351
16122394	667	676	paralysis	Disease	MESH:D010243
16122394	695	718	reactive oxygen species	Chemical	MESH:D017382
16122394	768	777	glycitein	Chemical	MESH:C086566
16122394	789	794	Abeta	Gene	351
16122394	814	823	paralysis	Disease	MESH:D010243
16122394	842	852	C. elegans	Species	328850
16122394	916	933	hydrogen peroxide	Chemical	MESH:D006861
16122394	952	962	C. elegans	Species	328850
16122394	995	1004	glycitein	Chemical	MESH:C086566
16122394	1023	1046	reactive oxygen species	Chemical	MESH:D017382
16122394	1113	1123	C. elegans	Species	328850
16122394	1133	1142	glycitein	Chemical	MESH:C086566
16122394	1239	1253	soy isoflavone	Chemical	MESH:D007529
16122394	1254	1263	glycitein	Chemical	MESH:C086566
16122394	1277	1282	Abeta	Gene	351
16122394	1283	1291	toxicity	Disease	MESH:D064420
16122394	1350	1355	Abeta	Gene	351
16122394	1422	1427	Abeta	Gene	351
16122394	1439	1466	neurodegenerative disorders	Disease	MESH:D019636
16122394	Negative_Correlation	MESH:D007529	MESH:D019636
16122394	Negative_Correlation	MESH:C086566	MESH:D019636
16122394	Positive_Correlation	MESH:D010243	351
16122394	Negative_Correlation	MESH:D007529	351
16122394	Association	MESH:D064420	351
16122394	Negative_Correlation	MESH:C086566	MESH:D017382
16122394	Negative_Correlation	MESH:C086566	MESH:D010243
16122394	Negative_Correlation	MESH:D007529	MESH:D064420
16122394	Negative_Correlation	MESH:C086566	MESH:D064420
16122394	Negative_Correlation	MESH:C086566	351
16122394	Negative_Correlation	MESH:C004742	351
16122394	Association	MESH:D019636	351

